We are buying today at open HGSI (NASDAQ) with strong results from its lupus drug and strong consensus

HGSI (NASDAQ) bought at open up above 15 usd

SQNM (NASDAQ) up 8% to 6,3 usd

We are selling PARD (NASDAQ) with 9% gain

TICKER            BUY AREA    QUOTE NOW     POSITION            DRIVER

HGSI (NASDAQ)  USD 14,42          15,65              LT                 LUPUS DRUG SUCCESSFUL
ARNA (NASDAQ)  USD 5,05            5      SHORT TERM     PENDING SEPTEMBER CLINICAL DATA
SQNM (NASDAQ) USD 5,85            6,35    SHORT TERM EARNING RELEASE AND PRODUCT UPDATE
TSPT (NASDAQ)  USD 7,8                8        LT INTERMEZZO PENDING FDA APPROVAL-PARTNERSHIP
ALXA (NASDAQ)  USD 2,28             2,6             LT       STRONG CONSENSUS
CYTK (NASDAQ) USD 3                   3             LT    STRONG CONSENSUS  PENDING CLINICAL DATA
ARIA (NASDAQ) USD 2,35           1,90 SOLD (-19%)
AEZS(NASDAQ)  USD 2,1            2,65            LT       STRONG CONSENSUS, PENDING DATA
JAV (AMEX)  USD 1,3               1,85                        STRONG CONSENSUS
NPSP (NASDAQ)      USD 4,7                  4               LT                STRONG CONSENSUS
ONXX(NASDAQ)       USD 35,9              36,3             LT                      NEXAVAR
IDIX (NASDAQ)        USD  4,44            4,2 SOLD(-5%)

SNTS (NASDAQ)     USD   2,81          3,25 SOLD(+17%)  

BFRM (NASDAQ)        USD   2,85          2,6             LONG TERM

OCLS (NASDAQ) USD 2,85      2,45 SOLD (-15%)                                

TRGT (NASDAQ) USD 5,5          8,7 SOLD(+60%) 

OREX (NASDAQ) USD 5,35     6,45 SOLD(+20%)  

FOLD (NASADQ) USD 10           10,6  LONG TERM     PLICERA, AMIGAL STRONG  CONSENSUS

SOMX (NASDAQ) USD 1,10       1,38   SOLD (+25%)    

DDSS (NASDAQ)  USD 2,65    1,95    HOLD  TRAZODONE manifacturing issue 7/24/09

XNPT (NASDAQ)  USD 21,85      21  LONG TERM    XP19986  POSITIVE TRIAL 6/30/09

VNDA (NASDAQ) 12,1                 15,2SOLD (+25%)       

CYTR (NASDAQ)   USD 1,02      1,1      LONG TERM    STRONG  CONSENSUS

JAZZ (NASDAQ)    USD 4,95     7,3 SOLD (+45%)  

PARD (NASDAQ)    USD 5          5,9      PROFIT TAKING(+18%)     

PARD (NASDAQ) USD 6,6 rebought 7/2    7,2 SOLD (+9%)  LONG TERM       STRONG CONSENSUS

INCY (NASDAQ) USD 3,5         5,2 SOLD (+50%)   

ISTA (NASDAQ) USD 4,1      5,1 LONG TERM          BEPREVE  FDA  PDUFA  9/12/09

SLXP (NASDAQ) USD 9,9       12,1  LONG TERM  STRONG CONSENSUS FDA  PDUFA 9/9/09

MAPP (NASDAQ) USD 11,3       10,1  REBUYING LONG TERM STRONG CONSENSUS 

ARYX (NASDAQ) USD            4,5       SOLD 2,5 (-45%)

GTXI (NASDAQ)   USD 9,5     10,2    LONG TERM         FDA  PDUFA 10/30/09

UTHR (NASDAQ) USD 84         96 SOLD (+15%) 

NGSX (NASDAQ) USD 6,4      8,2 SOLD(+30%)

VICL (NASDAQ)  USD 3         3,8 PRE-MKT.   LONG TERM      SWINE FLU

STAA (NASDAQ)  USD 3,3        2,7  LONG TERM   FDA CLEARENCE FOR Epiphany(TM)

ALTH (NASDAQ)  7,9              7,8   LONG TERM          FDA PDUFA 9/24/09

AMAG (NASDAQ) 52,8        45  LONG TERM        FDA APPROVES FERAHEME 6/30/09

XOMA (NASDAQ) 1,2    0,9    LONG TERM  OVERSOLD

HEB (AMEX)    3,3(5%OF CAPITAL)  2,25 SOLD(-35%)                                

HEB (AMEX) was rebought after 100% gain (see old posts)

MRNA (NASDAQ)  3,3            1,4 SOLD (-55%)    

RIGL (NASDAQ) USD 10           10,1 SOLD  FLAT

MITI (NASDAQ) USD 6              6,2       LONG TERM      OVERSOLD

MNKD (NASDAQ) USD 8,3         7,95    SOLD(-4%)    

SVNT (NASDAQ) USD 7,10        13       SOLD(+90%)

NPSP (NASDAQ) 3,1 USD        4,75     SOLD(+50%)

SCLN (NASDAQ) 2,25 USD        2,7     SOLD (+20%)  LONG TERM ZADAXIN SALES

MAPP (NASDAQ) 8 USD  (posts from 5/26)  PROFIT TAKED(+45%)   LEVADEX

VNDA (NASDAQ) 8 USD (see old post 5/8)  PROFIT TAKED(+80%)     FANAT

CLDA (NASDAQ) 15,7 USD       14,7  LONG TERM   OVERSOLD

CTIC (NASDAQ) 2,10 USD        1,39 SOLD (-35%)

ANPI (NASDAQ) 2 USD           1,39 SOLD(-30%)

MEDX (NASDAQ) 7,5 USD   8,7  PROFIT TAKING(+20%)  LTERM RECENT PRODUCTS RESULTS

MNTA (NASDAQ) 8,9 USD      11  LONG TERM   STRONG CONSENSUS

ACAD (NASDAQ) 2,6 USD     5 SOLD (+95%)   

ACOR (NASDAQ) 24 USD    24,3  LONG TERM FAMPRIDINE-SR, FDA PDUFA 10/22/09

BDSI (NASDAQ)                           PROFIT TAKED 6,3  (+18%)  

BDSI (NASDAQ)  6,6 rebought   5,75      SHORT TERM    ONSOLIS APPROVED BY FDA

DNDN (NASDAQ)  22 USD (see old post 4/27) 24,5  LONG TERM  PROVENGE

SPPI (NASDAQ)  4 USD (see ols post 5/12)    6/12  PROFIT TAKING (+35%)

SPPI (NASDAQ)  5,85 USD         7,4      PROFIT TAKING(+28%) 

SPPI (NASDAQ)  6,5 USD rebought 7/2  7,3 LT  ZEVALIN FDA PDUFA  09/07/09

FUSILEV PDUFA 08/10/09